Cargando…
Nucleus-selective codelivery of proteins and drugs for synergistic antitumor therapy
Subcellular organelle targeted transport is of great significance for accurately delivering drugs to active sites for better pharmacological effects, but there are still a lot of challenges due to transport problems. In addition, the killing effect of one kind of drug on cells is limited. Therefore,...
Autores principales: | Yang, Lan, Ma, Huijie, Lin, Shan, Zhu, Yupeng, Chen, Hui, Zhang, Ning, Feng, Xuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473504/ https://www.ncbi.nlm.nih.gov/pubmed/36277647 http://dx.doi.org/10.1039/d2sc03861g |
Ejemplares similares
-
Clickable amino acid tuned self-assembly of a nucleus-selective multi-component nanoplatform for synergistic cancer therapy
por: Yang, Lan, et al.
Publicado: (2021) -
Codelivery of Doxorubicin and Paclitaxel by Cross-Linked
Multilamellar Liposome Enables Synergistic Antitumor Activity
por: Liu, Yarong, et al.
Publicado: (2014) -
Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy
por: Zhao, Ting, et al.
Publicado: (2022) -
Microemulsion-based synergistic dual-drug codelivery system for enhanced apoptosis of tumor cells
por: Qu, Ding, et al.
Publicado: (2015) -
Nano lipidic carriers for codelivery of sorafenib and ganoderic acid for enhanced synergistic antitumor efficacy against hepatocellular carcinoma
por: Wang, Bin, et al.
Publicado: (2021)